Short Interest in Cooper Companies, Inc. (The) (COO) Rises By 46.8%

Cooper Companies, Inc. (The) (NYSE:COO) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 1,006,178 shares, a growth of 46.8% from the August 31st total of 685,240 shares. Based on an average trading volume of 630,438 shares, the days-to-cover ratio is presently 1.6 days. Currently, 2.1% of the shares of the company are sold short.

Several research analysts recently commented on COO shares. Zacks Investment Research cut Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Monday, September 18th. Jefferies Group LLC reaffirmed a “buy” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Stephens restated an “equal weight” rating and set a $250.00 target price (up previously from $235.00) on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Oppenheimer Holdings, Inc. reissued a “hold” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Finally, Robert W. Baird restated a “buy” rating and issued a $273.00 target price (up previously from $267.00) on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Cooper Companies, Inc. (The) currently has a consensus rating of “Buy” and an average target price of $261.67.

Get Cooper Companies Inc. (The) alerts:

In other news, VP Randal Golden sold 1,621 shares of the business’s stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total transaction of $394,956.65. Following the transaction, the vice president now owns 1,731 shares in the company, valued at approximately $421,758.15. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Paul L. Remmell sold 9,294 shares of the business’s stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the transaction, the chief executive officer now owns 6,186 shares in the company, valued at approximately $1,536,973.56. The disclosure for this sale can be found here. Insiders sold 14,892 shares of company stock valued at $3,678,270 over the last three months. 1.60% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. ProVise Management Group LLC lifted its holdings in Cooper Companies, Inc. (The) by 0.6% in the second quarter. ProVise Management Group LLC now owns 1,177 shares of the medical device company’s stock valued at $282,000 after buying an additional 7 shares during the period. YorkBridge Wealth Partners LLC grew its stake in Cooper Companies, Inc. (The) by 2.1% during the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after purchasing an additional 11 shares during the period. Creative Planning grew its stake in Cooper Companies, Inc. (The) by 0.8% during the second quarter. Creative Planning now owns 1,909 shares of the medical device company’s stock worth $457,000 after purchasing an additional 16 shares during the period. CIBC Asset Management Inc grew its stake in Cooper Companies, Inc. (The) by 0.3% during the second quarter. CIBC Asset Management Inc now owns 4,697 shares of the medical device company’s stock worth $1,125,000 after purchasing an additional 16 shares during the period. Finally, Wedbush Securities Inc. grew its stake in Cooper Companies, Inc. (The) by 1.0% during the second quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock worth $427,000 after purchasing an additional 18 shares during the period. Institutional investors own 95.79% of the company’s stock.

Cooper Companies, Inc. (NYSE COO) opened at 240.56 on Tuesday. Cooper Companies, Inc. has a 1-year low of $158.73 and a 1-year high of $256.39. The firm has a 50-day moving average price of $243.33 and a 200 day moving average price of $228.36. The firm has a market cap of $11.78 billion, a price-to-earnings ratio of 34.50 and a beta of 0.54.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, topping the Zacks’ consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The company had revenue of $556.00 million for the quarter, compared to analyst estimates of $552.32 million. During the same period in the previous year, the firm earned $2.30 earnings per share. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. Equities analysts predict that Cooper Companies, Inc. will post $9.73 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/10/03/short-interest-in-cooper-companies-inc-the-coo-rises-by-46-8.html.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.